Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Open-label, Comparative Study to Estimate the Effect of Darbepoetin Alfa on Hospital Days, Economic Outcomes, and Health-related Quality of Life in Subjects With Nonmyeloid Malignancies and Anemia of Cancer

NCT00989092 is registered in ClinicalTrials.gov with Amgen as lead sponsor.

NCT NCT00989092
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00989092 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Open-label, Comparative Study to Estimate the Effect of Darbepoetin Alfa on Hospital Days, Economic Outcomes, and Health-related Quality of Life in Subjects With Nonmyeloid Malignancies and Anemia of Cancer
Lead sponsor
Amgen
Phase
Phase 2
Overall status
Terminated
Start date
May 31, 2002
Completion date
June 30, 2004
Enrollment
287 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

anemia, anemia of cancer, cancer, carcinoma, neoplasms, non-myeloid malignancies